Kaltreider H B
Pulmonary and Critical Care Medicine Section, Department of Veterans Affairs Medical Center, San Francisco, CA 94121.
West J Med. 1993 Nov;159(5):570-8.
Although the cause and development of most inflammatory and fibrotic interstitial lung diseases are unknown, both the antigenic stimuli and the immunopathogenic mechanisms that produce the syndrome of hypersensitivity pneumonitis have been well described. Hypersensitivity pneumonitis is a group of related inflammatory and fibrotic interstitial lung diseases that result from hypersensitivity immune reactions to the repeated inhalation of antigens derived from fungal, bacterial, animal protein, and reactive chemical sources. Immune complex-induced inflammatory reactions initiate acute lung injury; T cell-mediated hypersensitivity reactions perpetuate it and induce chronic inflammatory, granulomatous, and fibrotic responses in the interstitium of the lungs. Because the natural history of many interstitial lung diseases of unknown causes involves the progressive evolution through these same phases, knowledge about immune pathogenesis gained from studies of hypersensitivity pneumonitis may provide a way to understand the causes and development of other interstitial lung diseases.
尽管大多数炎症性和纤维化间质性肺病的病因及发展尚不清楚,但引发过敏性肺炎综合征的抗原刺激和免疫致病机制已得到充分描述。过敏性肺炎是一组相关的炎症性和纤维化间质性肺病,由对反复吸入源自真菌、细菌、动物蛋白和活性化学物质的抗原产生的超敏免疫反应所致。免疫复合物诱导的炎症反应引发急性肺损伤;T细胞介导的超敏反应使其持续,并在肺间质中诱导慢性炎症、肉芽肿和纤维化反应。由于许多病因不明的间质性肺病的自然病程都涉及这些相同阶段的逐步演变,因此从过敏性肺炎研究中获得的免疫发病机制知识可能为理解其他间质性肺病的病因及发展提供一种途径。